Skip to main content
ISEV2025 Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Late Breaking Oral

Disease and therapy

Session Name:: LB01 EV in Disease and Therapy
Chair: Christian Preußer
Co-Chair: Jasper van den Ende

LB01.4 - TNFα inhibitor Thalidomide enhances Osteosarcoma Chemotherapy Sensitivity

Sunday, April 27, 2025
09:15 – 09:30 CET
Location: Lehar 3-4

    Presenting Author(s)

  • JL

    Jianlong Li, n/a

    Southern Medical University
    Guanghzou, China (People's Republic)